🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lauren Gilstrap

Dartmouth College

ORCID: 0000-0002-5716-8176

Also affiliated with Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth–Hitchcock Medical Center, Dartmouth Health

MedicineEconomics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.344Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization

Mayo Clinic Proceedings Innovations Quality & Outcomes(2020)10.1016/j.mayocpiqo.2020.05.007
Top 51%
0.344DataRank
Top 51%5 citations

Marat Fudim, Antonio L. Pérez, Matthew Nayor, Natasha M. Lever, David S. Raymer +6 more

Papers

Driven by 7 papers — median percentile 49. Top paper: “Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization”.

Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization

Mayo Clinic Proceedings Innovations Quality & Outcomes(2020)10.1016/j.mayocpiqo.2020.05.007
Top 51%
0.344DataRank
Top 51%5 citations

Marat Fudim, Antonio L. Pérez, Matthew Nayor, Natasha M. Lever, David S. Raymer +6 more

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

Circulation(2021)10.1161/circulationaha.121.055816
N/A
0DataRank · unranked
126 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim Hayek, Aarti Asnani +58 more

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

medRxiv(2021)10.1101/2021.02.28.21252516
N/A
0DataRank · unranked
14 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani +16 more

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry

European Journal of Cancer(2022)10.1016/j.ejca.2022.07.018
N/A
0DataRank · unranked
41 citations

Paul Guedeney, Nicholas Palaskas, Lorenz Lehmann, Stéphane Éderhy, Han Zhu +86 more

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Archives of cardiovascular diseases(2022)10.1016/j.acvd.2022.03.003
N/A
0DataRank · unranked
40 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani +61 more

The Association Between Beta-blocker and Renin–Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients

Journal of Cardiac Failure(2022)10.1016/j.cardfail.2022.11.010
N/A
0DataRank · unranked
7 citations

Nicole Solomon, Karen Chiswell, A. James O’Malley, Jonathan Skinner, Gregg C. Fonarow +4 more

Variation in Risk‐Standardized Acute Admission Rates Among Patients With Heart Failure in Accountable Care Organizations: Implications for Quality Measurement

Journal of the American Heart Association(2023)10.1161/jaha.122.029758
N/A
0DataRank · unranked
0 citations

Peter K. Lindenauer, Kamal Faridi, Aruna Priya, Penelope S. Pekow, Thomas D’Aunno +7 more